Stock listing

NASDAQ:VTYX Ventyx Biosciences Inc Stock

Follow Ventyx Biosciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:VTYX

$14.00 USD

Close on Mar 3, 2026 · No longer trades

Oct 21, 2021 to last close -33.4% · weekly closes, Oct 21, 2021 – Mar 3, 2026
Lowest – highest close
$0.836 – $46.65 USDSince Oct 21, 2021 · lowest Apr 7, 2025 · highest Mar 3, 2023

Delisted NASDAQ:VTYX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:VTYX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Ventyx Biosciences Inc on 6ix

Calls
6 calls with a replay · 6 with a transcript · latest May 9, 2024
Decks
9 decks · latest Oct 22, 2025

Events

CallWhenStatus
Ventyx Biosciences (VTYX) Q1 2024 Earnings CallThu, May 09, 2024 · 4:30 PM ETReplay
Ventyx Biosciences (VTYX) Q2 2023 Earnings CallThu, Aug 10, 2023 · 4:30 PM ETReplay
Ventyx Biosciences (VTYX) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
Ventyx Biosciences (VTYX) Q4 2022 Earnings CallThu, Mar 23, 2023 · 4:30 PM ETReplay
Ventyx Biosciences (VTYX) Q2 2022 Earnings CallMon, Aug 15, 2022 · 4:30 PM ETReplay
Ventyx Biosciences (VTYX) Q1 2022 Earnings CallThu, May 12, 2022 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (October 2025)Technical30 slidesOct 22, 2025
Investor Presentation (January 2025)Investor deck40 slidesJan 14, 2025
Technical Presentation (November 2023)Technical14 slidesNov 6, 2023
Technical Presentation (October 2023)Technical20 slidesOct 10, 2023
Investor Day (January 2023)Investor day72 slidesJan 26, 2023
Investor Presentation (November 2022)Investor deck44 slidesNov 30, 2022
Investor Presentation (June 2022)Investor deck37 slidesJun 29, 2022
Investor Presentation (March 2022)Investor deck36 slidesMar 15, 2022
Investor Presentation (November 2021)Investor deck33 slidesNov 30, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sheila Gujrathi
Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Gossamer Bio, Inc. (President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – May 10, 2018 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past)
Director · Since at least Oct 20, 2021
Aaron E. Royston
Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); Achieve Life Sciences, Inc. (Director · Since at least Apr 16, 2026); RayzeBio, Inc. (Director · Sep 14, 2023 – Sep 14, 2023 · Past); Akero Therapeutics Inc (Director · Jun 19, 2019 – Jun 24, 2019 · Past)
Director · Oct 20, 2021 – Jun 9, 2022 · Past
Jörn Drappa
Other companies: Alumis Inc. (Chief Medical Officer · Since at least Jun 27, 2024); Alpine Immune Sciences Inc (Director · Jul 18, 2022 – May 20, 2024 · Past); Viela Bio Inc (Chief Medical Officer · Oct 2, 2019 – Mar 13, 2021 · Past)
Chief Medical Officer · Oct 20, 2021 – Feb 4, 2022 · Past
Onaiza Cadoret-Manier
Other companies: Ardelyx, Inc. (Director · Since at least Mar 12, 2020); Ionis Pharmaceuticals, Inc. (EVP,Chf GL Pdt Str & Oper Ofc · Jan 9, 2020 – Feb 2, 2024 · Past)
Director · Since at least Jan 11, 2023
William Richard White
Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Akero Therapeutics Inc (Chief Financial Officer · Since at least Jun 19, 2019)
Director · Since at least Oct 20, 2021
Mark S Forman
Other companies: Passage Bio, Inc. (CHIEF MEDICAL OFFICER · Mar 30, 2022 – Mar 15, 2024 · Past)
Chief Medical Officer · Since at least Aug 12, 2024
Matthew Richard Moore
Other companies: Arcutis Biotherapeutics, Inc. (SVP and Chief Business Officer · Jan 11, 2021 – May 1, 2024 · Past)
Chief Operating Officer · Since at least May 16, 2024
Richard Gaster
Other companies: Elevation Oncology Inc (Director · Jun 24, 2021 – Jun 24, 2021 · Past)
Director · Oct 20, 2021 – Jun 9, 2022 · Past
Somu Subramaniam
Other companies: icad inc (Director · Dec 30, 2010 – Sep 28, 2018 · Past)
Director · Since at least Oct 20, 2021
Allison HulmeDirector · Since at least Jan 11, 2023
All 17 people
PersonSeat
Christopher W KruegerCHIEF BUSINESS OFFICER · Oct 20, 2021 – Apr 2, 2024 · Past
Jigar ChokseyDirector · Oct 20, 2021 – Jun 9, 2022 · Past
John NussCHIEF SCIENTIFIC OFFICER · Since at least Oct 20, 2021
Martin AusterCHIEF FINANCIAL OFFICER · Oct 20, 2021 – Apr 2, 2024 · Past
Raju MohanCEO AND PRESIDENT, Director · Since at least Oct 20, 2021
Roy GonzalesSenior VP, Finance · Since at least Aug 30, 2024
William J SandbornSee Remarks · May 9, 2022 – Aug 31, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Ventyx Biosciences Inc.